Today: 16 May 2026

Internet Access in Mozambique

Internet Access in Mozambique

Tmcel is restructuring to avoid bankruptcy after accumulating over $400 million in debt. Vodacom Mozambique holds about half the mobile market and launched the country's first limited 5G service in Maputo in 2023. By early 2024, there were 18.91 million active mobile SIMs, covering roughly 55% of the population. Fixed-line broadband remains rare, and about one-third of Mozambicans lack mobile broadband coverage.
23 February 2025
··
Internet Access in Libya: A Comprehensive Overview

Internet Access in Libya: A Comprehensive Overview

Libya had 12.4 million active mobile connections by June 2023, about 179% of its population. State firms dominate the sector, with Libyana and Al-Madar Al-Jadeed covering most of the country’s 4G users. Fixed broadband remains limited at 326,000 subscriptions in 2022. Libya ranked 161st of 179 countries for mobile speed in 2023, with median downloads of 8–16 Mbps.
16 February 2025
··
Internet Access in China

Internet Access in China

China had 1.09 billion internet users by end-2023, with over 99% on mobile. State-owned ISPs—China Telecom, China Unicom, and China Mobile—control regional access and backbone networks. All international traffic passes through three government-run gateways, slowing foreign site access. The Great Firewall blocks major foreign platforms and censors content; VPN use is tightly restricted.
10 February 2025
···········
Internet Access in Syria

Internet Access in Syria

Syria opened public internet access around 2000, years after establishing its first connection in 1997. By 2010–2011, about 4.5 million Syrians were online, but the government kept strict control over infrastructure and content. As of 2021, internet penetration reached 46–47%, still well below the regional average.
7 February 2025
··
Google’s Bard ‘Learnt Bengali’ Claim Has a Data Problem, Former Researcher Says

Google’s Bard ‘Learnt Bengali’ Claim Has a Data Problem, Former Researcher Says

A former Google AI researcher says Google’s claim that its Bard system “learned” Bengali on its own is misleading, citing company data showing Bengali was already in its training mix. The dispute follows a 2023 “60 Minutes” segment where Google executives called Bard’s language abilities a “black box.” Bard has since been rebranded as Gemini and integrated into Google’s core products.
6 July 2024
·
Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test

Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test

Nanox.AI, formerly Zebra Medical Vision, is now the imaging software unit of Nasdaq-listed Nanox, which acquired Zebra for $100 million in 2021. The company reported losses and financing risk in its 2026 filing but said it added Cedars-Sinai as a trial partner and accelerated U.S. deployment of its Nanox.ARC systems. NICE approved Nanox AI tools for NHS use during a three-year evidence period. FDA cleared its HealthFLD liver analysis software in 2024.
2 February 2024
·
AI Layoffs in 2023: The Real Number Was 4,247, and the Next Wave Is Harder to Count

AI Layoffs in 2023: The Real Number Was 4,247, and the Next Wave Is Harder to Count

U.S. employers cited artificial intelligence in 4,247 announced job cuts in 2023, according to Challenger, Gray & Christmas. By March 2026, AI was the top stated reason for U.S. job cuts that month, with 15,341 announced. The broader labor market showed 6.866 million job openings in March 2026, while layoffs remained at 1.2%, according to the Labor Department.
6 March 2023
···
1 … 1,941 1,942 1,943

Stock Market Today

  • AstraZeneca Shares Dip 10% in 3 Months Amid Valuation Debate
    May 16, 2026, 10:56 AM EDT. AstraZeneca (LSE:AZN) shares fell about 10% over three months, closing at £136.32 with a market cap near £211 billion. Despite recent weakness, the firm posted $60.4 billion in revenue and $10.4 billion net income. The stock shows a 34.27% total shareholder return over one year and 86.21% over five years, signaling strong long-term growth. Analysts suggest a fair value of £163.06, implying the stock is 16.4% undervalued, supported by a robust pipeline in oncology and rare diseases expected to generate $10 billion in peak revenues. Risks include potential trial failures and pricing pressures on key drugs. The market may be balancing growth optimism with near-term uncertainties in healthcare sector valuations.

Latest articles

Devon Energy Jumps on Friday, Faces Investors’ Next Move Monday

Devon Energy Jumps on Friday, Faces Investors’ Next Move Monday

16 May 2026
Devon Energy shares surged 4.76% to $49.49 Friday, outperforming peers as crude prices climbed and investors reacted to its completed Coterra merger. The company announced an $8 billion buyback and raised its dividend to $0.320 per share. U.S. crude settled at $105.42 a barrel. Devon reported first-quarter net earnings of $120 million and $1.7 billion in operating cash flow.
Starbucks Heads for Monday Breakout Test After $400 Million Layoffs

Starbucks Heads for Monday Breakout Test After $400 Million Layoffs

16 May 2026
Starbucks will cut 300 U.S. corporate jobs and close several regional support offices, part of its “Back to Starbucks” turnaround plan. The company expects $400 million in restructuring charges, mostly non-cash write-downs. Shares closed Friday at $106.82, near a 52-week high, after reporting 6.2% global comparable sales growth last quarter. The cuts do not affect cafe workers.
NextEra Shares Face Monday After $400 Billion Dominion Report Over Weekend

NextEra Shares Face Monday After $400 Billion Dominion Report Over Weekend

16 May 2026
NextEra Energy shares fell 2.42% to $93.36 Friday after reports of possible merger talks with Dominion Energy, a deal that could value the combined utility at about $400 billion including debt. Both companies declined to comment. Dominion closed at $61.73, down 2%. Investors await any official statements or deal terms before markets reopen Monday.
Atlassian Shares Jump 8% on Friday, Eyes on Monday for AI Interest

Atlassian Shares Jump 8% on Friday, Eyes on Monday for AI Interest

16 May 2026
Atlassian shares jumped 8.16% to $87.46 Friday but ended the week down 4.5%. Truist Securities reiterated a Buy rating and $100 target after the Team 26 event, citing AI monetization as a key issue. Nasdaq regular trading resumes Monday. Atlassian last posted a fiscal Q3 revenue gain of 32% year-over-year to $1.787 billion but reported a GAAP operating loss of $56.3 million.
Go toTop